Epigenetics and Heart Failure.

Int J Mol Sci · 2020 · PMC7729735 · PMID 33260869

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

narrowly missed statistical significanceno p-value reported

Apabetalone, a bromodomain (BRDU) inhibitor, has recently been tested in a large phase III clinical trial and the results only narrowly missed statistical significance [ 54 ] (updated findings were disclosed in AHA-2019).

also in 227 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.